CIK 0001840706
- Accelerated filer
- Emerging growth company
SOPHiA GENETICS SA
Sign in to watch- Ticker
- SOPH
- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Other
- Phone
- +41 216941060
- Business address
- LA PIECE, CH-1180, ROLLE, Switzerland, 00000
- 4/A Grant or award Chief Sales Officer acquired 56,468 shares (grant or award)
- 4/A Grant or award Chief People Officer acquired 71,869 shares (grant or award)
- 4/A Grant or award Chief Scientific Officer acquired 112,936 shares (grant or award)
- 4/A Grant or award Chief Technology Officer acquired 82,136 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 82,136 shares (grant or award)
- 4 Grant or award President acquired 431,211 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 112,936 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 112,936 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 431,211 shares (grant or award)
- 4 Grant or award Chief Sales Officer acquired 56,468 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 112,936 shares (grant or award)
- 4 Grant or award Chief People Officer acquired 71,869 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 97,536 shares (grant or award)
- 4 Open-market sale Chief Sales Officer sold 3 shares at $4.71 ($14)
- 4 Planned sale Chief Legal Officer sold 684 shares at $4.79 ($3,274)
- 4 Planned sale Chief Executive Officer sold 4,486 shares at $4.77 ($21,410)
- 4 Planned sale Chief Medical Officer sold 608 shares at $4.79 ($2,913)
- 4 Planned sale Chief Scientific Officer sold 608 shares at $4.78 ($2,907)
- 4 Planned sale Chief People Officer sold 380 shares at $4.79 ($1,818)
- 4 Planned sale President sold 1,183 shares at $4.79 ($5,671)
Page 7 of 8 · 157 filings